These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32414711)

  • 61. Delineating clinical characteristics and comorbidities among 206 COVID-19 deceased patients in India: Emerging significance of renin angiotensin system derangement.
    Majeed J; Ajmera P; Goyal RK
    Diabetes Res Clin Pract; 2020 Sep; 167():108349. PubMed ID: 32712124
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
    Sun ML; Yang JM; Sun YP; Su GH
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):219-222. PubMed ID: 32164092
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.
    Kai H; Kai M
    Hypertens Res; 2020 Jul; 43(7):648-654. PubMed ID: 32341442
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications.
    Davidson AM; Wysocki J; Batlle D
    Hypertension; 2020 Nov; 76(5):1339-1349. PubMed ID: 32851855
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].
    Kreutz R; Abd El-Hady Algharably E; Ganten D; Messerli F
    Pneumologie; 2020 Sep; 74(9):611-614. PubMed ID: 32916743
    [No Abstract]   [Full Text] [Related]  

  • 67. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
    Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK
    Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
    Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
    Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
    [No Abstract]   [Full Text] [Related]  

  • 69. Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.
    Sackin H
    Med Hypotheses; 2021 Jul; 152():110609. PubMed ID: 34048987
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relationship Between ACE2 and Other Components of the Renin-Angiotensin System.
    Cohen JB; Hanff TC; Bress AP; South AM
    Curr Hypertens Rep; 2020 Jun; 22(7):44. PubMed ID: 32591908
    [TBL] [Abstract][Full Text] [Related]  

  • 71. COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?
    Kutti Sridharan G; Kotagiri R; Chandiramani VH; Mohan BP; Vegunta R; Vegunta R; Rokkam VRP
    Am J Ther; 2020; 27(4):e400-e402. PubMed ID: 32366740
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV.
    Li SR; Tang ZJ; Li ZH; Liu X
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1021-1026. PubMed ID: 32285293
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
    Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19.
    Matsuzawa Y; Kimura K; Ogawa H; Tamura K
    Hypertens Res; 2022 Jul; 45(7):1147-1153. PubMed ID: 35581498
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The RAAS and SARS-CoV-2: A riddle to solve].
    Choi M; Aiello EA; Ennis IL; Villa-Abrille MC
    Hipertens Riesgo Vasc; 2020; 37(4):169-175. PubMed ID: 32527699
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Drugs acting on renin angiotensin system and use in ill patients with COVID-19.
    Alexandre J; Cracowski JL; Richard V; Bouhanick B;
    Therapie; 2020; 75(4):319-325. PubMed ID: 32553503
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Can a Combination of AT1R Antagonist and Vitamin D Treat the Lung Complication of COVID-19?
    Rafiullah M
    Am J Med Sci; 2020 Oct; 360(4):338-341. PubMed ID: 32736832
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
    Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19.
    Sparks MA; South A; Welling P; Luther JM; Cohen J; Byrd JB; Burrell LM; Batlle D; Tomlinson L; Bhalla V; Rheault MN; Soler MJ; Swaminathan S; Hiremath S
    Clin J Am Soc Nephrol; 2020 May; 15(5):714-716. PubMed ID: 32220930
    [No Abstract]   [Full Text] [Related]  

  • 80. [Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus].
    Cano F; Gajardo M; Freundlich M
    Rev Chil Pediatr; 2020 Jun; 91(3):330-338. PubMed ID: 32730512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.